These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8369038)

  • 1. Cost-effective treatment of Candida esophagitis.
    Neely D
    Ann Intern Med; 1993 May; 118(10):824; author reply 825. PubMed ID: 8369038
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effective treatment of Candida esophagitis.
    Thio CL; Rutledge TM
    Ann Intern Med; 1993 May; 118(10):824-5. PubMed ID: 8470860
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effective treatment of Candida esophagitis.
    Legg JJ; Brossier KA; Goldschmidt RH
    Ann Intern Med; 1993 May; 118(10):824-5. PubMed ID: 8470859
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial.
    Laine L; Dretler RH; Conteas CN; Tuazon C; Koster FM; Sattler F; Squires K; Islam MZ
    Ann Intern Med; 1992 Oct; 117(8):655-60. PubMed ID: 1308663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effective treatment of Candida esophagitis.
    Berman DS; Wenglin BD
    Ann Intern Med; 1993 May; 118(10):824. PubMed ID: 8470858
    [No Abstract]   [Full Text] [Related]  

  • 6. [Candida esophagitis treated with a single dose of fluconazole in patients with HIV: presentation of 11 cases].
    Roig P; Martínez A; Salavert M; Nieto A; Navarro V; Medina E; Carrasco R
    Enferm Infecc Microbiol Clin; 1990 Nov; 8(9):544-7. PubMed ID: 2099854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome.
    Tavitian A; Raufman JP; Rosenthal LE; Weber J; Webber CA; Dincsoy HP
    Gastroenterology; 1986 Feb; 90(2):443-5. PubMed ID: 3510145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to fluconazole and amphotericin B in a patient with AIDS who was being treated for candidal esophagitis.
    Le TP; Tuazon CU; Levine M; Borum M; Rollhauser C
    Clin Infect Dis; 1996 Sep; 23(3):649-50. PubMed ID: 8879803
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
    Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
    Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketoconazole treatment of Candida esophagitis--a prospective study of 12 cases.
    Fazio RA; Wickremesinghe PC; Arsura EL
    Am J Gastroenterol; 1983 May; 78(5):261-4. PubMed ID: 6303114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida esophagitis complicated by esophageal stricture.
    Hyun JJ; Chun HJ; Keum B; Seo YS; Kim YS; Jeen YT; Lee HS; Um SH; Kim CD; Ryu HS
    Endoscopy; 2010; 42 Suppl 2():E180-1. PubMed ID: 20640980
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.
    Vazquez JA
    HIV Clin Trials; 2000; 1(1):47-59. PubMed ID: 11590489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS.
    Gil A; Lavilla P; Valencia E; Pintado V; Dupla ML; Khamashta MA; García-Puig J; Ortiz-Vázquez J
    Postgrad Med J; 1991 Jun; 67(788):548-52. PubMed ID: 1924024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient achalasia-like esophageal motility disorder after candida esophagitis in a boy with chronic granulomatous disease.
    Bode CP; Schroten H; Koletzko S; Lübke H; Wahn V
    J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):320-3. PubMed ID: 8890086
    [No Abstract]   [Full Text] [Related]  

  • 15. Rationalizing prescribing for oral and oesophageal candidiasis.
    Taylor CB; Finlay R; Richardson C; Bunting P; Welch J
    Int J STD AIDS; 1996 Oct; 7(6):452. PubMed ID: 8940678
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
    Parente F; Ardizzone S; Cernuschi M; Antinori S; Esposito R; Moroni M; Lazzarin A; Bianchi Porro G
    Am J Gastroenterol; 1994 Mar; 89(3):416-20. PubMed ID: 8122656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The therapy of Candida esophagitis in AIDS patients with fluconazole].
    Heise W; Arasteh K; L'age M
    Mycoses; 1990; 33 Suppl 1():32-6. PubMed ID: 2101862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine].
    Brockmeyer NH; Hantschke D; Olbricht T; Hengge UA; Goos M
    Mycoses; 1991; 34 Suppl 1():83-6. PubMed ID: 1818270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida oesophagitis incidentally detected by fluorine-18 fluorodeoxyglucose positron emission tomography in a patient with sarcoidosis.
    Furukawa D; Ohtani K; Kawahara T; Yakabe D; Tsutsui H
    Eur Heart J Cardiovasc Imaging; 2017 Nov; 18(11):1300. PubMed ID: 28950355
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
    Barbaro G; Barbarini G; Di Lorenzo G
    Chest; 1996 Dec; 110(6):1507-14. PubMed ID: 8989069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.